RAMini: Mini-laparotomy Versus Mini Lumbotomy

Sponsor
Central Hospital, Nancy, France (Other)
Overall Status
Unknown status
CT.gov ID
NCT02888613
Collaborator
(none)
206
2
16

Study Details

Study Description

Brief Summary

This study aims to compare the results of two mini invasive surgical approaches in abdominal aortic surgery: mini lumbotomy with retroperitoneal approach versus mini laparotomy with transperitoneal approach. Respiratory and renal functions and recovery of intestinal transit will be assessed after 30 days.

The secondary purpose of this study is to assess the life quality and morbi-mortality at 30 days, as well as at 6 and 12 months.

Condition or Disease Intervention/Treatment Phase
  • Procedure: mini laparotomy
  • Procedure: mini lumbotomy
N/A

Detailed Description

Following abdominal aortic surgery, post-operative outcomes are considered favorable with a rapid recovery of respiratory, renal functions and intestinal transit, with limited cardiac events. Complications are still frequent after the classic open abdominal surgery.

In abdominal aortic surgery, "mini" abdominal incision has been proposed as an alternative to the classic large surgical approach.

Two mini surgical approaches are possible: mini lumbotomy with retroperitoneal approach, and mini laparatomy with transperitoneal approach.

Previous studies have only compared classic versus mini surgical approaches and many are retrospectives studies. Pain control through the mini-incision surgery allowed early mobilization of patients, improved lung function, reduced muscle loss, and favoured intestinal motility.

So far, no study has compared the results of two mini invasive aortic approaches.

The aim of this prospective randomized study is to compare two mini-invasive surgical approaches and to determine which of them allows the improvement of surgical outcomes with less morbi-mortality.

Study Design

Study Type:
Interventional
Anticipated Enrollment :
206 participants
Allocation:
Randomized
Intervention Model:
Parallel Assignment
Masking:
None (Open Label)
Primary Purpose:
Other
Official Title:
Prospective Randomized Study of Two Aortic Surgical Approaches: Mini-laparotomy Versus Mini Lumbotomy
Anticipated Study Start Date :
Sep 1, 2018
Anticipated Primary Completion Date :
Jan 1, 2019
Anticipated Study Completion Date :
Jan 1, 2020

Arms and Interventions

Arm Intervention/Treatment
Other: Mini laparotomy

Patients with surgical indication to mini invasive aortic repair will be operated after randomisation with transperitoneal approach

Procedure: mini laparotomy
The patient will be positioned supine. After induction of general anesthesia, a median umbilical incision will be performed. The average length of the incision of the laparotomy will be 10 cm (8-12 cm). The small intestine will be then mobilized medially and held by an orthostatic retractor. Arterial dissection and control as well as bypasses will be performed according to the conventional technique. In case of occlusive disease of the iliac arteries, femoral site will be selected to achieve the distal anastomoses of the bifurcated prosthetic graft.
Other Names:
  • transperitoneal approach
  • Other: Mini lumbotomy

    Patients with surgical indication to mini invasive aortic repair will be operated after randomisation with retroperitoneal approach

    Procedure: mini lumbotomy
    After induction of general anesthesia, the patient will be positioned in right lateral decubitus at 45° of the table plane. The incision will be performed from the tip of the eleventh rib with a slightly sloping path to the outer edge of the rectus muscle. The average length of the incision of the laparotomy will be 10 cm (8-12 cm). Abdominal aorta will be approached retroperitoneally. Arterial dissection and control as well as bypasses will be performed according to the conventional retroperitoneal technique. In case of occlusive disease of the iliac arteries, femoral site will be selected to achieve the distal anastomoses of the bifurcated prosthetic graft.
    Other Names:
  • retro-peritoneal approach
  • Outcome Measures

    Primary Outcome Measures

    1. Respiratory recovery [day 30]

      evaluated with respiratory function test (Sniff nasal inspiratory pressure, SNIP test)

    2. Renal recovery [day 30]

      evaluated by blood creatinine level, uremia and kalemia

    3. Intestinal transit recovery [day 30]

      evaluated by reapparition of gas and transit

    Secondary Outcome Measures

    1. Respiratory recovery [day 1]

      evaluated by SNIP test

    2. Respiratory recovery [day 3]

      evaluated by SNIP test

    3. Respiratory recovery [day 5]

      evaluated by SNIP test

    4. Renal recovery [day 1]

      evaluated by creatinine clearance, uremia and kaliemia

    5. Renal recovery [day 3]

      evaluated by creatinine clearance, uremia and kaliemia

    6. Renal recovery [day 5]

      evaluated by creatinine clearance, uremia and kaliemia

    7. Intestinal recovery [day 1]

      assessment of intestinal transit (stool emission)

    8. Intestinal recovery [day 3]

      assessment of intestinal transit (stool emission)

    9. Intestinal recovery [day 5]

      assessment of intestinal transit (stool emission)

    10. Post-operative pain assessment [day 1]

      with VAS scale

    11. Post-operative pain assessment [day 3]

      with VAS scale

    12. Post-operative pain assessment [day 5]

      with VAS scale

    13. Quality of life assessment [after 6 months]

      by using SF-12 questionnaire

    14. Quality of life assessment [after 1 year]

      by using SF-12 questionnaire

    15. Morbi-mortality [after 6 months]

      evaluated by EQ-5D questionnaire

    16. Morbi-mortality [after 1 year]

      evaluated by EQ-5D questionnaire

    17. Morbi-mortality [day 30]

      evaluated by non-recovery of functions, eventration and death

    Eligibility Criteria

    Criteria

    Ages Eligible for Study:
    18 Years and Older
    Sexes Eligible for Study:
    All
    Accepts Healthy Volunteers:
    No
    Inclusion Criteria:
    • Elective abdominal aortic repair.

    • Abdominal aneurysm or occlusive aortic disease requiring intervention.

    • Written consent previously provided by the patient.

    • Affiliation to social security.

    • Preliminary medical examination.

    Exclusion Criteria:
    • Hostile abdomen.

    • Juxta renal abdominal aortic aneurysm.

    • Aneurysmal extension to the iliac arteries.

    • Concomitant visceral arteries lesions.

    • Urgent surgery.

    • Contraindication to surgery.

    Contacts and Locations

    Locations

    No locations specified.

    Sponsors and Collaborators

    • Central Hospital, Nancy, France

    Investigators

    • Principal Investigator: Nicla Settembre, MD, PhD, Department of vascular and endovascular surgery. Nancy University Hospital

    Study Documents (Full-Text)

    None provided.

    More Information

    Publications

    None provided.
    Responsible Party:
    Central Hospital, Nancy, France
    ClinicalTrials.gov Identifier:
    NCT02888613
    Other Study ID Numbers:
    • 2016-A00990-51
    First Posted:
    Sep 5, 2016
    Last Update Posted:
    Sep 18, 2018
    Last Verified:
    Sep 1, 2018
    Individual Participant Data (IPD) Sharing Statement:
    No
    Plan to Share IPD:
    No
    Studies a U.S. FDA-regulated Drug Product:
    No
    Studies a U.S. FDA-regulated Device Product:
    No
    Keywords provided by Central Hospital, Nancy, France
    Additional relevant MeSH terms:

    Study Results

    No Results Posted as of Sep 18, 2018